{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Mind Medicine (MindMed) Inc."},"Symbol":{"label":"Symbol","value":"MNMD"},"Address":{"label":"Address","value":"1055 WEST HASTINGS STREET,SUITE 1700, VANCOUVER, V6E 2E9, United States"},"Phone":{"label":"Phone","value":"+1 650 208-2454"},"Industry":{"label":"Industry","value":" Medicinal Chemicals and Botanical Products "},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies."},"CompanyUrl":{"label":"Company Url","value":"https://www.mindmed.co"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Daniel R. Karlin","title":"Chief Medical Officer"},{"name":"Robert Barrow","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}